Overview
Effect of Intraoperative Dexmedetomidine on Postoperative Delirium in Elderly Patients Undergoing Robot-assisted Pancreaticoduodenectomy: a Randomized Controlled Study
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2024-04-01
2024-04-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To observe the effect of intraoperative dexmedetomidine on the incidence of postoperative delirium, postoperative analgesic drug requirements and pain scores in elderly patients undergoing robot-assisted pancreaticoduodenectomy.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Chinese PLA General HospitalCollaborator:
Beijing Tiantan HospitalTreatments:
Dexmedetomidine
Criteria
Inclusion Criteria:- Patients over 65 years old
- Patients undergoing elective robotic-assisted pancreaticoduodenectomy.
- Written informed consent was obtained.
Exclusion Criteria:
- Patients with severe preoperative cognitive impairment (MMSE ≤ 20) who are unable to
undergo a follow-up evaluation.
- Patients with history of psychiatric or neurological disorders.
- Patients with body mass index ≤ 18 or ≥ 30
- Pregnant or lactating women
- Patients with severe bradycardia (heart rate less than 40 beats per minute)
- Patients with pathological sinus node syndrome or grade 2 or greater AV block
- Patients with severe hepatic or renal insufficiency.
- Patients with severe hypertension (systolic blood pressure ≥ 180 mmHg or diastolic
blood pressure ≥ 110 mmHg)